Janet Wolter

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2

New England Journal of Medicine · 2001 · 8,905 citations

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after…

Journal of Clinical Oncology · 1999 · 2,255 citations